当前位置：
X-MOL 学术
›
Cancer Biol. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2024-01-04 , DOI: 10.1080/15384047.2023.2299288 Zhenyuan Qian 1 , Wenfa Lin 2 , Xufan Cai 2 , Jianzhang Wu 1 , Kun Ke 1 , Zaiyuan Ye 1 , Fang Wu 1
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2024-01-04 , DOI: 10.1080/15384047.2023.2299288 Zhenyuan Qian 1 , Wenfa Lin 2 , Xufan Cai 2 , Jianzhang Wu 1 , Kun Ke 1 , Zaiyuan Ye 1 , Fang Wu 1
Affiliation
Gastric cancer (GC) has been a major health burden all over the world but there are fewer promising chemotherapeutic drugs due to its multidrug resistance. It has been reported that WYC-209 suppres...
中文翻译：
WYC-209通过RARα下调WNT4抑制GC恶性进展
胃癌（GC）一直是全世界的主要健康负担，但由于其多重耐药性，有希望的化疗药物较少。据报道，WYC-209 抑制...
更新日期：2024-01-05
中文翻译：
WYC-209通过RARα下调WNT4抑制GC恶性进展
胃癌（GC）一直是全世界的主要健康负担，但由于其多重耐药性，有希望的化疗药物较少。据报道，WYC-209 抑制...
京公网安备 11010802027423号